WHODrug: A Global, Validated and Updated Dictionary for Medicinal Information
暂无分享,去创建一个
Malin Fladvad | Marie Lindquist | Olof Lagerlund | Sara Strese | M. Lindquist | Malin Fladvad | Sara Strese | Olof Lagerlund
[1] L. Fauchier,et al. Three case reports of involuntary muscular movements as adverse reactions to sacubitril/valsartan , 2018, British journal of clinical pharmacology.
[2] N. Vargesson. Thalidomide‐induced teratogenesis: History and mechanisms , 2015, Birth defects research. Part C, Embryo today : reviews.
[3] Zhengwu Lu,et al. Technical challenges in designing post-marketing eCRFs to address clinical safety and pharmacovigilance needs. , 2010, Contemporary clinical trials.
[4] I. Edwards,et al. Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre , 2019, Pharmacoepidemiology and drug safety.
[5] G. N. Norén,et al. Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports , 2019, Drug Safety.
[6] G. Jaya Nair. Ensuring quality in the coding process: A key differentiator for the accurate interpretation of safety data , 2013, Perspectives in clinical research.
[7] S. Pal,et al. WHO programme for international drug monitoring , 2013 .
[8] J. Venulet,et al. Drug Recording and Classification by the WHO Research Centre for International Monitoring of Adverse Reactions to Drugs , 1974, Methods of Information in Medicine.
[9] J. Venulet,et al. WHO’s International Drug Monitoring — The Formative Years, 1968–1975 , 2010, Drug safety.
[10] Antoni F. Z. Wisniewski,et al. Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR , 2019, Drug Safety.
[11] M. Lindquist. VigiBase, the WHO Global ICSR Database System: Basic Facts , 2008 .
[12] Organización Mundial de la Salud. Guidelines for ATC classification and DDD assignment , 1996 .
[13] G. N. Norén,et al. Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites , 2015, Drug Safety.
[14] Sarah Watson,et al. Desogestrel and panic attacks – a new suspected adverse drug reaction reported by patients and health care professionals on spontaneous reports , 2018, British journal of clinical pharmacology.
[15] Deven Babre,et al. Medical Coding in Clinical Trials , 2010, Perspectives in clinical research.